LIGHT is one of the ligands of herpes virus entry mediator (HVEM, also termed TNFRSF14), and the conjugation of two molecules facilitates anti-tumoral or pro-tumoral immunity, depending on the histological type of cancer (Han et al., 2019). Here, TNFSF14 is linked to cancer.